Teladoc Health Inc (TDOC) (Q3 2026) Earnings Call Highlights: Integrated Care Margin
Teladoc Health (TDOC) reported Q3 2026 revenue of $605M, near guidance, with adjusted EBITDA of $79M, up 13.5% YoY. Integrated Care margins expanded 180 bps to 18.8%. BetterHelp insurance revenue hit $32M, but total revenue declined 3.4% YoY due to cash pay business headwinds. The company added 3,000 therapists, bringing total to 11,000. Free cash flow was $76M, with $850M in cash. Management expects continued cash pay pressure but sees growth in insurance.
How this was made

The 30-second read
Why it matters
The earnings beat on adjusted EBITDA suggests short‑term price support, but revenue weakness tempers enthusiasm.
Market read
First report of Teladoc's Q3 2026 results; material numbers for a mid‑cap digital health company.
What to watch
Insurance‑driven growth and therapist capacity expansion may improve future margins.
Background
Teladoc Health released its Q3 2026 earnings call transcript, highlighting performance metrics and guidance.
Ticker impact
Q3 2026 revenue of $605M near guidance and adjusted EBITDA of $79M beat the high end, with margin expansion to 18.8%.
potential modest upside as the EBITDA beat offsets revenue weakness
Investors focus on profitability beat; however, revenue fell YoY, limiting upside.
Market effects
Telehealth sector may see renewed interest in integrated‑care profitability models.
U.S. healthcare stocks could experience modest ripple effects.
Limited to investors tracking digital health earnings trends.
Counterpoint
Revenue decline and cash‑pay pressure could signal longer‑term headwinds.
Key entities
- ExecutiveCharles Divita
CEO of Teladoc Health, provided commentary on earnings and outlook.
- ExecutiveMike Grasher
CFO of Teladoc Health, discussed financial results.





